Head-to-Head Startup Ranking & Discovery
AAlgen Biotechnologies logo

Algen Biotechnologies

AI · US · Early-stage
algenbio.com
AI-powered Drug DiscoveryArtificial IntelligenceCRISPR

Algen is using CRISPR to uncover disease-driving RNA messages to find treatments for cancer, inflammation and diseases with high unmet needs. We are harnessing the power of CRISPR and machine learning to find first-in-class drugs that modulate RNA messages at single-cell resolution. Algen's founders are bioengineer from Jennifer Doudna Lab and biotech commercialization expert, teamed up with experienced pharmaceutical executives.

Founded
2020
Headquarters
San Francisco, CA, USA
Team size
11–50
Stage
Early-stage
📊 Coliseo ratings
🏆 Overall 1496 Elo
1494
💰 Conviction
Provisional
1503
🔥 Momentum
Provisional
1490
🧲 Talent
Provisional
Total matchups0
⚔️ Vote on today's matchups →

Ratings are live Elo scores from head-to-head crowd votes — opinion, not fact or financial advice. How it works →